BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 37290481)

  • 21. Completeness of Reporting Oligometastatic Disease Characteristics in the Literature and Influence on Oligometastatic Disease Classification Using the ESTRO/EORTC Nomenclature.
    Nevens D; Jongen A; Kindts I; Billiet C; Deseyne P; Joye I; Lievens Y; Guckenberger M
    Int J Radiat Oncol Biol Phys; 2022 Nov; 114(4):587-595. PubMed ID: 35738308
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Assessing resectability of colorectal liver metastases: How do different subspecialties interpret the same data?
    Aubin JM; Bressan AK; Grondin SC; Dixon E; MacLean AR; Gregg S; Tang P; Kaplan GG; Martel G; Ball CG
    Can J Surg; 2018 Aug; 61(4):251-256. PubMed ID: 30067183
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Surgical management of oligometastatic disease in gastric cancer.
    Jin P; Ji X; Tian Y
    Clin Res Hepatol Gastroenterol; 2020 Oct; 44(5):638-645. PubMed ID: 32147440
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Recent Treatment Patterns of Oropharyngeal Cancer in Korea Based on the Expert Questionnaire Survey of the Korean Society for Head and Neck Oncology (KSHNO).
    Choi KH; Song JH; Kim YS; Kim JH; Jeong WJ; Nam IC; Kim JH; Ahn HK; Chun SH; Hong HJ; Joo YH; Eun YG; Moon SH; Lee J
    Cancer Res Treat; 2021 Oct; 53(4):1004-1014. PubMed ID: 33540495
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Incidence and survival of patients with oligometastatic esophagogastric cancer: A multicenter cohort study.
    Kroese TE; Christ SM; van Rossum PSN; Burger MDL; Buijs GS; Mühlematter U; Andratschke N; Ruurda JP; Hüllner M; Gutschow CA; van Hillegersberg R; Guckenberger M
    Radiother Oncol; 2022 Aug; 173():269-276. PubMed ID: 35753555
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Stereotactic body radiation therapy in the treatment of cancer patients with oligometastatic disease: a real world study.
    Stefanovic M; Calvet G; Pérez-Montero H; Esteve A; Bujalance MV; Navarro-Martín A; Fernández MDA; González FF; Borras SM; Borbalas AL; Fernandez MN; Garau MM; Calduch AL; Edo FG
    Clin Transl Oncol; 2023 Jan; 25(1):199-206. PubMed ID: 36068449
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Global survey on the surgical management of patients affected by colorectal cancer with synchronous liver metastases: impact of surgical specialty and geographic region.
    Sijberden JP; Spinelli A; Ferrero A; Chand M; Wexner S; Besselink MG; Dagher I; Zimmitti G; Görgec B; de Lacy A; Roy M; Tanis P; Tonti C; Abu Hilal M
    Surg Endosc; 2023 Jun; 37(6):4658-4672. PubMed ID: 36879167
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pattern of practice for postoperative management of endometrial cancer in Korea: a survey by the Korean Gynecologic Oncology Group and the Korean Radiation Oncology Group (KGOG 2028-KROG 2104).
    Lee SU; Kim JY; Kim MK; Kim YS; Kim YJ; Eom KY; Wee CW
    J Gynecol Oncol; 2023 Jul; 34(4):e54. PubMed ID: 36998224
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Older patients and adjuvant therapy for colorectal cancer: surgeon knowledge, opinions, and practice.
    Jorgensen ML; Young JM; Solomon MJ
    Dis Colon Rectum; 2011 Mar; 54(3):335-41. PubMed ID: 21304306
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Radiotherapy in oligometastatic prostate cancer-a pattern of care survey among members of the German Society for Radiation Oncology (DEGRO).
    Rogowski P; Trapp C; von Bestenbostel R; Konnerth D; Marschner S; Schmidt Hegemann NS; Belka C; Li M
    Strahlenther Onkol; 2022 Aug; 198(8):727-734. PubMed ID: 35364690
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Defining oligometastatic non-small cell lung cancer: A simulated multidisciplinary expert opinion.
    Hendriks LEL; Dooms C; Berghmans T; Novello S; Levy A; De Ruysscher D; Hasan B; Giaj Levra M; Giaj Levra N; Besse B; Vansteenkiste J; Dingemans AC;
    Eur J Cancer; 2019 Dec; 123():28-35. PubMed ID: 31655358
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Racial clustering and access to colorectal surgeons, gastroenterologists, and radiation oncologists by African Americans and Asian Americans in the United States: a county-level data analysis.
    Hayanga AJ; Waljee AK; Kaiser HE; Chang DC; Morris AM
    Arch Surg; 2009 Jun; 144(6):532-5. PubMed ID: 19528386
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tumor biology and multidisciplinary strategies of oligometastasis in gastrointestinal cancers.
    Zhao Y; Li J; Li D; Wang Z; Zhao J; Wu X; Sun Q; Lin PP; Plum P; Damanakis A; Gebauer F; Zhou M; Zhang Z; Schlösser H; Jauch KW; Nelson PJ; Bruns CJ
    Semin Cancer Biol; 2020 Feb; 60():334-343. PubMed ID: 31445220
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Management of Oligometastatic Disease in Esophagogastric Cancer: What Is the Evidence?
    Hingorani M; Stubley H
    Oncol Res Treat; 2023; 46(7-8):312-319. PubMed ID: 37331340
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Characteristics of attitude and recommendation of oncologists toward exercise in South Korea: a cross sectional survey study.
    Park JH; Oh M; Yoon YJ; Lee CW; Jones LW; Kim SI; Kim NK; Jeon JY
    BMC Cancer; 2015 Apr; 15():249. PubMed ID: 25886264
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Definitions and treatment of oligometastatic oesophagogastric cancer according to multidisciplinary tumour boards in Europe.
    Kroese TE; van Hillegersberg R; Schoppmann S; Deseyne PRAJ; Nafteux P; Obermannova R; Nordsmark M; Pfeiffer P; Hawkins MA; Smyth E; Markar S; Hanna GB; Cheong E; Chaudry A; Elme A; Adenis A; Piessen G; Gani C; Bruns CJ; Moehler M; Liakakos T; Reynolds J; Morganti A; Rosati R; Castoro C; D'Ugo D; Roviello F; Bencivenga M; de Manzoni G; Jeene P; van Sandick JW; Muijs C; Slingerland M; Nieuwenhuijzen G; Wijnhoven B; Beerepoot LV; Kolodziejczyk P; Polkowski WP; Alsina M; Pera M; Kanonnikoff TF; Nilsson M; Guckenberger M; Monig S; Wagner D; Wyrwicz L; Berbee M; Gockel I; Lordick F; Griffiths EA; Verheij M; van Rossum PSN; van Laarhoven HWM;
    Eur J Cancer; 2022 Mar; 164():18-29. PubMed ID: 35134666
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Oligo-metastatic neoPlasms from the gastro-intestinal tract: iDentIfiCaTIon of cliNical and molecular drivers: the PREDICTION study.
    Ottaiano A; De Luca A; Santorsola M; Scognamiglio G; Di Mauro A; Chiodini P; Lambiase M; Sacco A; Petrillo A; Granata V; Fusco R; Mercadante E; Martucci N; De Luca G; Rocca A; Celentano E; Crispo A; Di Gennaro P; Tatangelo F; Ferrara G; Izzo F; Belli A; Patrone R; Delrio P; Rega D; De Franciscis S; Muto P; Ravo V; Di Franco R; Borzillo V; Santagata S; Rea G; Castaldo D; Pace U; De Feo G; Scala S; Nasti G; Normanno N
    BMC Cancer; 2023 Oct; 23(1):1010. PubMed ID: 37858132
    [TBL] [Abstract][Full Text] [Related]  

  • 38. OLIGO-AIRO: a national survey on the role of radiation oncologist in the management of OLIGO-metastatic patients on the behalf of AIRO.
    Mazzola R; Jereczek-Fossa BA; Antognoni P; Di Muzio N; Nicosia L; Lancia A; Fazio I; Chiesa S; Osti MF; Pergolizzi S; Franceschini D; Gentile P; Triggiani L; Alongi F
    Med Oncol; 2021 Mar; 38(5):48. PubMed ID: 33761017
    [TBL] [Abstract][Full Text] [Related]  

  • 39. First-line treatment choices of Turkish medical oncologists in metastatic colorectal cancer: A survey study.
    Beypinar I; Araz M; Uysal M; Yalcin S
    J BUON; 2019; 24(1):68-76. PubMed ID: 30941953
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Use of a Novel Network-Based Linchpin Score to Characterize Accessibility to the Oncology Physician Workforce in the United States.
    Moen EL; Brooks GA; O'Malley AJ; Schaefer A; Carlos HA; Onega T
    JAMA Netw Open; 2022 Dec; 5(12):e2245995. PubMed ID: 36525275
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.